Not applicableWithdrawnNCT01539395What this trial is testingA Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple SclerosisWho this might be right forMultiple Sclerosis MSDx, Inc.
Not applicableEnded earlyNCT02949908What this trial is testingMEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)Who this might be right forMultiple Sclerosis Merck KGaA, Darmstadt, Germany 2
Testing effectiveness (Phase 2)Ended earlyNCT00745615What this trial is testingAn Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the DiseaseWho this might be right forRelapsing Remitting Multiple Sclerosis Teva Pharmaceutical Industries, Ltd. 257
Not applicableStudy completedNCT00818038What this trial is testingA Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder FunctionWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 30
Early research (Phase 1)UnknownNCT02903537What this trial is testingTolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)Who this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive Fundació Institut Germans Trias i Pujol 16
Not applicableStudy completedNCT04115930What this trial is testingCorrelation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS PatientsWho this might be right forRelapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more University of Eastern Finland 61
Not applicableTemporarily pausedNCT04031469What this trial is testingA Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseWho this might be right forGut MicrobiomeGastrointestinal MicrobiomeAutism+77 more ProgenaBiome 1,000
Not applicableStudy completedNCT01491100What this trial is testingNoninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple SclerosisWho this might be right forMultiple Sclerosis Bayer 1,085
Not applicableStudy completedNCT01112345What this trial is testingAn Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These ParametersWho this might be right forMultiple Sclerosis, Relapsing-Remitting Merck KGaA, Darmstadt, Germany 133
Early research (Phase 1)WithdrawnNCT00674141What this trial is testingNasal Administration of Dexamethasone for Multiple Sclerosis (MS) TreatmentWho this might be right forMS Patient With Relpasing Remitting Attacks Hadassah Medical Organization 10
Not applicableStudy completedNCT02305264What this trial is testingImaging of Intracerebral Inflammation in MSWho this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive Assistance Publique - Hôpitaux de Paris 61
Large-scale testing (Phase 3)Study completedNCT02290444What this trial is testingEffects of Acthar on Recovery From Cognitive Relapses in MSWho this might be right forMultiple Sclerosis State University of New York at Buffalo 64
Post-approval studies (Phase 4)Study completedNCT01705236What this trial is testingA 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®Who this might be right forRelapsing Remitting Multiple Sclerosis RRMS Novartis Pharmaceuticals 87
Large-scale testing (Phase 3)Active Not RecruitingNCT03477500What this trial is testingRandomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)Who this might be right forMultiple Sclerosis Haukeland University Hospital 100
Not applicableStudy completedNCT01909492What this trial is testingMeasurement of Relaxin Peptide in Multiple Sclerosis (MS)Who this might be right forMultiple Sclerosis, Relapsing-Remitting Providence Health & Services 30
Post-approval studies (Phase 4)Study completedNCT00176592What this trial is testingPhase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRIWho this might be right forMultiple Sclerosis University of Medicine and Dentistry of New Jersey 75
Post-approval studies (Phase 4)Study completedNCT01767493What this trial is testingStudy to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS PatientsWho this might be right forMultiple Sclerosis Institute for Neurodegenerative Disorders 19
Post-approval studies (Phase 4)UnknownNCT04048577What this trial is testingA Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of NatalizumabWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting Berkovich, Regina MD, PhD Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01405820What this trial is testingExploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)Who this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 290
Not applicableStudy completedNCT02247310What this trial is testingBETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With BetaferonWho this might be right forMultiple Sclerosis, Relapsing Remitting Bayer 498